卡妥昔单抗 T76941

Product Introduction
Bioactivity


英文名: Carotuximab

描述: Carotuximab（DE-122）是一种新型内胆苷抗体，具有强大的抗血管生成活性和抗炎活性。Carotuximab 可阻断内皮糖蛋白 (CD105) 及其下游 Smad 信号通路。Carotuximab 具有免疫调节和抗肿瘤作用，可预防高胆固醇血症和高血糖诱导的人内皮功能障碍。

体外活性: In human aortic endothelial cells, pretreatment with Carotuximab (TRC105) at a concentration of 300 μg/mL for 1 hour, followed by co-culture for 12 hours, resulted in the reduction of 7-ketocholesterol-induced endothelial glycoprotein (Eng) protein levels. Additionally, Carotuximab inhibited the pSmad1/5 and pSmad2/3 signaling pathways. The blockade of Eng by Carotuximab prevented 7-ketocholesterol-induced monocyte adhesion and migration through endothelial monolayer cells [1].

体内活性: In acute myeloid leukemia (AML) xenografts, the combination of Carotuximab (TRC105) and Decitabine, administered intravenously at a dose of 2 mg/kg once every 3 days for 8 weeks, produces a more durable anti-leukemia effect. Additionally, this combination enhances reactive oxygen species (ROS) activity [2].

存储条件: store at low temperaturestore at -80°C

关键字: DE122 | TRC-105 | TRC 105 | DE 122 | Carotuximab

相关产品: 3-Epiursolic acid | Meranzin | Seselin | 1,3,6-Tri-O-galloyl-beta-D-glucose | Fendosal | Chlorthenoxazine | Anti-inflammatory agent 34 | Homobutein | Myricetin 3-O-glucoside | Dehydropachymic acid

卡妥昔单抗 T76941信息由TargetMol中国为您提供，如您想了解更多关于卡妥昔单抗 T76941报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途